New IV pain relief combo for children enters final testing phase
NCT ID NCT07225634
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This study tests a new intravenous medicine called Combogesic IV, which combines two common pain relievers (acetaminophen and ibuprofen) into one infusion. It will involve 60 children aged 2 to 17 with acute pain who need IV pain relief. The goal is to see how the body processes the drug and to check its safety, with the hope of providing a non-opioid option for managing pain in kids.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Combogesic IV (a combination of acetaminophen and ibuprofen given through a vein)
What this could lead to
If successful, this could provide a safe, effective option for managing acute pain in children without relying on opioids.
What could go wrong
This is a small, early-stage trial focused on safety and drug processing, not on proving pain relief. The results may not apply to all children or pain types.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nemours Children's Health
Orlando, Florida, 32827, United States
Contact Phone: •••-•••-••••